KALVISTA PHARMACEUTICALS PROVIDES UPDATE ON STRONG EKTERLY® LAUNCH WITH PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 REVENUE RESULTS

Reuters · 01/08 21:05

Please log in to view news